 | • レポートコード：20QY06-00778 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、アンジオポエチン2のグローバル市場について種類別（Atu-111、BI-836880、LY-3127804、MEDI-3617、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・アンジオポエチン2市場の概要 ・世界の主要地域別アンジオポエチン2市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアンジオポエチン2市場規模2015-2026：種類別（Atu-111、BI-836880、LY-3127804、MEDI-3617、その他） ・世界のアンジオポエチン2市場規模2015-2026：用途別（病院、クリニック、その他） ・アンジオポエチン2の北米市場規模2015-2020 ・アンジオポエチン2のヨーロッパ市場規模2015-2020 ・アンジオポエチン2の中国市場規模2015-2020 ・アンジオポエチン2の日本市場規模2015-2020 ・アンジオポエチン2の東南アジア市場規模2015-2020 ・アンジオポエチン2のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Amgen Inc.、AnGes MG, Inc.、Boehringer Ingelheim GmbH、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、MedImmune, LLC、Regeneron Pharmaceuticals, Inc.、RXi Pharmaceuticals Corporation、Silence Therapeutics Plc、Synergys Biotherapeutics, Inc.） ・アンジオポエチン2の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アンジオポエチン2の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Angiopoietin 2 Market
The global Angiopoietin 2 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Angiopoietin 2 Scope and Market Size
The global Angiopoietin 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiopoietin 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Angiopoietin 2 market is segmented into
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segment by Application, the Angiopoietin 2 market is segmented into
Hospital
Clinic
Others
The Angiopoietin 2 market is analysed and market size information is provided by regions (countries). Segment by Application, the Angiopoietin 2 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angiopoietin 2 Market Share Analysis
Angiopoietin 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiopoietin 2 business, the date to enter into the Angiopoietin 2 market, Angiopoietin 2 product introduction, recent developments, etc.
The major vendors covered:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Table of Contents
1 Angiopoietin 2 Market Overview
1.1 Angiopoietin 2 Product Scope
1.2 Angiopoietin 2 Segment by Type
1.2.1 Global Angiopoietin 2 Sales by Type (2020-2026)
1.2.2 Atu-111
1.2.3 BI-836880
1.2.4 LY-3127804
1.2.5 MEDI-3617
1.2.6 Others
1.3 Angiopoietin 2 Segment by Application
1.3.1 Global Angiopoietin 2 Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Angiopoietin 2 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Angiopoietin 2 Sales Growth Rate (2015-2026)
1.4.2 Global Angiopoietin 2 Revenue and Growth Rate (2015-2026)
1.4.3 Global Angiopoietin 2 Price Trends (2015-2026)
2 Angiopoietin 2 Estimate and Forecast by Region
2.1 Global Angiopoietin 2 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Angiopoietin 2 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Angiopoietin 2 Sales Market Share by Region (2015-2020)
2.2.2 Global Angiopoietin 2 Revenue Market Share by Region (2015-2020)
2.3 Global Angiopoietin 2 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Angiopoietin 2 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Angiopoietin 2 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Angiopoietin 2 Estimates and Projections (2015-2026)
2.4.2 Europe Angiopoietin 2 Estimates and Projections (2015-2026)
2.4.3 China Angiopoietin 2 Estimates and Projections (2015-2026)
2.4.4 Japan Angiopoietin 2 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Angiopoietin 2 Estimates and Projections (2015-2026)
2.4.6 India Angiopoietin 2 Estimates and Projections (2015-2026)
3 Global Angiopoietin 2 Competition Landscape by Players
3.1 Global Top Angiopoietin 2 Players by Sales (2015-2020)
3.2 Global Top Angiopoietin 2 Players by Revenue (2015-2020)
3.3 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiopoietin 2 as of 2019)
3.4 Global Angiopoietin 2 Average Price by Company (2015-2020)
3.5 Manufacturers Angiopoietin 2 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Angiopoietin 2 Players (Opinion Leaders)
4 Global Angiopoietin 2 Market Size by Type
4.1 Global Angiopoietin 2 Historic Market Review by Type (2015-2020)
4.1.1 Global Angiopoietin 2 Sales Market Share by Type (2015-2020)
4.1.2 Global Angiopoietin 2 Revenue Market Share by Type (2015-2020)
4.1.3 Global Angiopoietin 2 Price by Type (2014-2020)
4.2 Global Angiopoietin 2 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Angiopoietin 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Angiopoietin 2 Revenue Forecast by Type (2021-2026)
4.2.3 Global Angiopoietin 2 Price Forecast by Type (2021-2026)
5 Global Angiopoietin 2 Market Size by Application
5.1 Global Angiopoietin 2 Historic Market Review by Application (2015-2020)
5.1.1 Global Angiopoietin 2 Sales Market Share by Application (2015-2020)
5.1.2 Global Angiopoietin 2 Revenue Market Share by Application (2015-2020)
5.1.3 Global Angiopoietin 2 Price by Application (2015-2020)
5.2 Global Angiopoietin 2 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Angiopoietin 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Angiopoietin 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiopoietin 2 Price Forecast by Application (2021-2026)
3 North America Angiopoietin 2 Market Facts & Figures
3.2 North America Angiopoietin 2 Sales Market Share by Company (2015-2020)
3.3 North America Angiopoietin 2 Sales Market Share by Type (2015-2020)
3.4 North America Angiopoietin 2 Sales Market Share by Application (2015-2020)
4 Europe Angiopoietin 2 Market Facts & Figures
4.2 Europe Angiopoietin 2 Sales Market Share by Company (2015-2020)
4.3 Europe Angiopoietin 2 Sales Market Share by Type (2015-2020)
4.4 Europe Angiopoietin 2 Sales Market Share by Application (2015-2020)
5 China Angiopoietin 2 Market Facts & Figures
5.2 China Angiopoietin 2 Sales Market Share by Company (2015-2020)
5.3 China Angiopoietin 2 Sales Market Share by Type (2015-2020)
5.4 China Angiopoietin 2 Sales Market Share by Application (2015-2020)
6 Japan Angiopoietin 2 Market Facts & Figures
6.2 Japan Angiopoietin 2 Sales Market Share by Company (2015-2020)
6.3 Japan Angiopoietin 2 Sales Market Share by Type (2015-2020)
6.4 Japan Angiopoietin 2 Sales Market Share by Application (2015-2020)
7 Southeast Asia Angiopoietin 2 Market Facts & Figures
7.2 Southeast Asia Angiopoietin 2 Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Angiopoietin 2 Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Angiopoietin 2 Sales Market Share by Application (2015-2020)
8 India Angiopoietin 2 Market Facts & Figures
8.2 India Angiopoietin 2 Sales Market Share by Company (2015-2020)
8.3 India Angiopoietin 2 Sales Market Share by Type (2015-2020)
8.4 India Angiopoietin 2 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Angiopoietin 2 Business
12.1 Amgen Inc.
12.1.1 Amgen Inc. Angiopoietin 2 Corporation Information
12.1.2 Amgen Inc. Angiopoietin 2 Business Overview and Total Revenue
12.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Inc. Angiopoietin 2 Products Offered
12.1.5 Amgen Inc. Recent Development
12.2 AnGes MG, Inc.
12.2.1 AnGes MG, Inc. Angiopoietin 2 Corporation Information
12.2.2 AnGes MG, Inc. Angiopoietin 2 Business Overview and Total Revenue
12.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
12.2.5 AnGes MG, Inc. Recent Development
12.3 Boehringer Ingelheim GmbH
12.3.1 Boehringer Ingelheim GmbH Angiopoietin 2 Corporation Information
12.3.2 Boehringer Ingelheim GmbH Angiopoietin 2 Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
12.3.5 Boehringer Ingelheim GmbH Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Angiopoietin 2 Corporation Information
12.4.2 Eli Lilly and Company Angiopoietin 2 Business Overview and Total Revenue
12.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
12.4.5 Eli Lilly and Company Recent Development
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Business Overview and Total Revenue
12.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
12.5.5 F. Hoffmann-La Roche Ltd. Recent Development
12.6 MedImmune, LLC
12.6.1 MedImmune, LLC Angiopoietin 2 Corporation Information
12.6.2 MedImmune, LLC Angiopoietin 2 Business Overview and Total Revenue
12.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
12.6.5 MedImmune, LLC Recent Development
12.7 Regeneron Pharmaceuticals, Inc.
12.7.1 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Corporation Information
12.7.2 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Business Overview and Total Revenue
12.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
12.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
12.8 RXi Pharmaceuticals Corporation
12.8.1 RXi Pharmaceuticals Corporation Angiopoietin 2 Corporation Information
12.8.2 RXi Pharmaceuticals Corporation Angiopoietin 2 Business Overview and Total Revenue
12.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
12.8.5 RXi Pharmaceuticals Corporation Recent Development
12.9 Silence Therapeutics Plc
12.9.1 Silence Therapeutics Plc Angiopoietin 2 Corporation Information
12.9.2 Silence Therapeutics Plc Angiopoietin 2 Business Overview and Total Revenue
12.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
12.9.5 Silence Therapeutics Plc Recent Development
12.10 Synergys Biotherapeutics, Inc.
12.10.1 Synergys Biotherapeutics, Inc. Angiopoietin 2 Corporation Information
12.10.2 Synergys Biotherapeutics, Inc. Angiopoietin 2 Business Overview and Total Revenue
12.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
12.10.5 Synergys Biotherapeutics, Inc. Recent Development
13 Angiopoietin 2 Manufacturing Cost Analysis
13.1 Angiopoietin 2 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Angiopoietin 2
13.4 Angiopoietin 2 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Angiopoietin 2 Distributors List
14.3 Angiopoietin 2 Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Angiopoietin 2 Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Angiopoietin 2 Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Angiopoietin 2 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Angiopoietin 2 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Angiopoietin 2 Sales Market Share by Region (2015-2020)
Table 6. Global Angiopoietin 2 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Angiopoietin 2 Revenue Share by Region (2015-2020)
Table 8. Global Angiopoietin 2 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Angiopoietin 2 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Angiopoietin 2 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Angiopoietin 2 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Angiopoietin 2 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Angiopoietin 2 Sales Share by Company (2015-2020)
Table 14. Global Angiopoietin 2 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Angiopoietin 2 Revenue Share by Company (2015-2020)
Table 16. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiopoietin 2 as of 2019)
Table 17. Global Angiopoietin 2 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Angiopoietin 2 Manufacturing Sites and Area Served
Table 19. Manufacturers Angiopoietin 2 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Angiopoietin 2 Players
Table 22. Global Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Angiopoietin 2 Sales Share by Type (2015-2020)
Table 24. Global Angiopoietin 2 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Angiopoietin 2 Price (K Pcs) by Type (2015-2020)
Table 26. Global Angiopoietin 2 Sales Share by Type (2021-2026)
Table 27. Global Angiopoietin 2 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Angiopoietin 2 Revenue Share by Type (2021-2026)
Table 29. Global Angiopoietin 2 Price (K Pcs) by Type (2021-2026)
Table 30. Global Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Angiopoietin 2 Sales Share by Application (2015-2020)
Table 32. Global Angiopoietin 2 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Angiopoietin 2 Price (K Pcs) by Application (2015-2020)
Table 34. Global Angiopoietin 2 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Angiopoietin 2 Sales Share by Application (2021-2026)
Table 36. Global Angiopoietin 2 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Angiopoietin 2 Revenue Share by Application (2021-2026)
Table 38. Global Angiopoietin 2 Price (K Pcs) by Application (2021-2026)
Table 39. United States Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 41. United States Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 43. United States Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 45. Europe Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 47. Europe Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 49. Europe Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 51. China Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 52. China Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 53. China Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 54. China Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 55. China Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 56. China Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 57. Japan Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 59. Japan Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 61. Japan Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 69. India Angiopoietin 2 Sales (K Pcs) by Company (2015-2020)
Table 70. India Angiopoietin 2 Sales Market Share by Company (2015-2020)
Table 71. India Angiopoietin 2 Sales (K Pcs) by Type (2015-2020)
Table 72. India Angiopoietin 2 Sales Market Share by Type (2015-2020)
Table 73. India Angiopoietin 2 Sales (K Pcs) by Application (2015-2020)
Table 74. India Angiopoietin 2 Sales Market Share by Application (2015-2020)
Table 75. Amgen Inc. Corporation Information
Table 76. Amgen Inc. Description and Business Overview
Table 77. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Amgen Inc. Angiopoietin 2 Product
Table 79. Amgen Inc. Recent Development
Table 80. AnGes MG, Inc. Corporation Information
Table 81. AnGes MG, Inc. Description and Business Overview
Table 82. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. AnGes MG, Inc. Angiopoietin 2 Product
Table 84. AnGes MG, Inc. Recent Development
Table 85. Boehringer Ingelheim GmbH Corporation Information
Table 86. Boehringer Ingelheim GmbH Description and Business Overview
Table 87. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim GmbH Angiopoietin 2 Product
Table 89. Boehringer Ingelheim GmbH Recent Development
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Eli Lilly and Company Angiopoietin 2 Product
Table 94. Eli Lilly and Company Recent Development
Table 95. F. Hoffmann-La Roche Ltd. Corporation Information
Table 96. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 97. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product
Table 99. F. Hoffmann-La Roche Ltd. Recent Development
Table 100. MedImmune, LLC Corporation Information
Table 101. MedImmune, LLC Description and Business Overview
Table 102. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. MedImmune, LLC Angiopoietin 2 Product
Table 104. MedImmune, LLC Recent Development
Table 105. Regeneron Pharmaceuticals, Inc. Corporation Information
Table 106. Regeneron Pharmaceuticals, Inc. Description and Business Overview
Table 107. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product
Table 109. Regeneron Pharmaceuticals, Inc. Recent Development
Table 110. RXi Pharmaceuticals Corporation Corporation Information
Table 111. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. RXi Pharmaceuticals Corporation Description and Business Overview
Table 113. RXi Pharmaceuticals Corporation Angiopoietin 2 Product
Table 114. RXi Pharmaceuticals Corporation Recent Development
Table 115. Silence Therapeutics Plc Corporation Information
Table 116. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Silence Therapeutics Plc Description and Business Overview
Table 118. Silence Therapeutics Plc Angiopoietin 2 Product
Table 119. Silence Therapeutics Plc Recent Development
Table 120. Synergys Biotherapeutics, Inc. Corporation Information
Table 121. Synergys Biotherapeutics, Inc. Description and Business Overview
Table 122. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product
Table 124. Synergys Biotherapeutics, Inc. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Angiopoietin 2 Distributors List
Table 128. Angiopoietin 2 Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiopoietin 2 Product Picture
Figure 2. Global Angiopoietin 2 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Angiopoietin 2 Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Angiopoietin 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Angiopoietin 2 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Angiopoietin 2 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Angiopoietin 2 Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Angiopoietin 2 Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Angiopoietin 2 Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Angiopoietin 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Angiopoietin 2 Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Angiopoietin 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Angiopoietin 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Angiopoietin 2 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Angiopoietin 2 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Angiopoietin 2 Players Market Share by Revenue in Angiopoietin 2 2015 & 2019
Figure 27. Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Angiopoietin 2 Revenue Share by Type (2015-2020)
Figure 29. Global Angiopoietin 2 Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Angiopoietin 2 Revenue Share by Application (2015-2020)
Figure 31. Global Angiopoietin 2 Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Angiopoietin 2 Sales Market Share by Type in 2019
Figure 33. United States Angiopoietin 2 Sales Market Share by Type in 2019
Figure 34. Europe Angiopoietin 2 Sales Market Share by Company in 2019
Figure 35. Europe Angiopoietin 2 Sales Market Share by Type in 2019
Figure 36. Europe Angiopoietin 2 Sales Market Share by Application in 2019
Figure 37. China Angiopoietin 2 Sales Market Share by Company in 2019
Figure 38. China Angiopoietin 2 Sales Market Share by Type in 2019
Figure 39. China Angiopoietin 2 Sales Market Share by Application in 2019
Figure 40. Japan Angiopoietin 2 Sales Market Share by Company in 2019
Figure 41. Japan Angiopoietin 2 Sales Market Share by Type in 2019
Figure 42. Japan Angiopoietin 2 Sales Market Share by Application in 2019
Figure 43. Southeast Asia Angiopoietin 2 Sales Market Share by Company in 2019
Figure 44. Southeast Asia Angiopoietin 2 Sales Market Share by Type in 2019
Figure 45. Southeast Asia Angiopoietin 2 Sales Market Share by Application in 2019
Figure 46. India Angiopoietin 2 Sales Market Share by Company in 2019
Figure 47. India Angiopoietin 2 Sales Market Share by Type in 2019
Figure 48. India Angiopoietin 2 Sales Market Share by Application in 2019
Figure 49. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AnGes MG, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. MedImmune, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Regeneron Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. RXi Pharmaceuticals Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Silence Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Synergys Biotherapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Angiopoietin 2
Figure 61. Manufacturing Process Analysis of Angiopoietin 2
Figure 62. Angiopoietin 2 Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
圧迫衣服の世界市場レポート2020 Market Analysis and Insights: Global Compression Garments Market The global Compression Garments market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Compression Garments Scope and Market Size The global Compr…- 胆道カテーテルの世界市場レポート2020 Market Analysis and Insights: Global Biliary Catheters Market The global Biliary Catheters market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Biliary Catheters Scope and Market Size The global Biliary Cathet…
- 足病治療ワークステーションの世界市場レポート2020 Podiatry is a branch of medicine devoted to the study, diagnosis, and medical and surgical treatment of disorders of the foot, ankle and lower extremity. The key factors contributing to the podiatry workstations market are the increasing incidence of diabetes and foot related disorders. Market Analy…
- 空カプセルの世界市場レポート2020 The growing applications of empty capsules in the nutraceutical industry (the use of nutraceutical products to treat lifestyle-related disorders such as high blood pressure, obesity, and diabetes) are another major factor driving the growth of this market. Factors such as the growing demand for hydr…
- ハードカプセルの世界市場レポート2020 A recently published report by QY Research titled Global Hard Capsules Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data…